In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Salmedix Inc.

Division of Teva Pharmaceutical Industries Ltd.
www.salmedix.com

Latest From Salmedix Inc.

Karyopharm Scores $48M Series B To Advance Early Cancer Compounds

The Massachusetts biotech has remained well-funded despite shying away from venture capital investors and seeking funds from private investors.

BioPharmaceutical Business Strategies

Financings Of The Fortnight: Thiel Looks To Bridge The Pre-Venture Capital Funding Gap For Biotech

Plus news on recent financing activity by Alcresta, Alder Biopharmaceuticals, H.I.G Capital and Supernus Pharmaceuticals.

BioPharmaceutical Business Strategies

H.I.G. BioVentures Closes Second Fund Above Target, Team Upbeat

H.I.G. Capital announced the closing of BioVentures II, a diversified life science venture fund focusing on drugs, medical devices, and diagnostics.

North America

Hamade's Compass Leads to Aberdare

In the eyes of one West Coast device VC, Sami Hamade has the perfect resume to be a venture capitalist. He spent over a decade at Guidant creating or funding new start-up ventures, both internally and externally. He's sat on boards, demonstrated market savvy and established connections with all the right venture firms and laboratories in Silicon Valley. Now Hamade is prepared to do the job at Aberdare Ventures, a small but highly regarded venture firm based in San Francisco.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • David S Kabakoff, Chmn. & CEO
    Anita Busquets, CFO
    Alan S Rosenthal, MD, Pres. & CSO
    Patrick Multani, VP, Clinical Dev.
  • Contact Info
  • Salmedix Inc.
    Phone: (858) 622-5050
    9380 Judicial Dr.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register